Skip to main content
. 2019 Jul 2;2019(7):CD011785. doi: 10.1002/14651858.CD011785.pub2

Han 2001.

Methods Clinical trial in China.
Participants Inclusion criteria: newborns age 1 to 12 days. Most infants with severe illness. Term and preterm.
Exclusion criteria: if swallowed maternal blood, bleeding outside gastrointestinal tract, abnormal clotting, constipation, necrotising enterocolitis.
Interventions Intervention (n = 43): cimetidine 5 mg/kg per day for 5 days.
Control (n = 40): no cimetidine.
Outcomes Acute gastric mucosal lesion (diagnosed by vomiting of bright red or coffee‐like liquid or faecal occult blood positive or tarry stool).
Notes Authors did not believe there were any adverse reactions attributable to the intervention.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Reported 'random'.
Allocation concealment (selection bias) Unclear risk Method not reported.
Blinding of participants and personnel (performance bias) 
 All outcomes Unclear risk Not reported.
Blinding of outcome assessment (detection bias) 
 All outcomes Unclear risk Not reported.
Incomplete outcome data (attrition bias) 
 All outcomes Low risk None reported.
Selective reporting (reporting bias) Unclear risk No protocol available.
Other bias Low risk Similar baseline characteristics between groups.